These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 5627465)
1. [Stromal reaction of the breast cancer tissue and its relation to prognosis]. Fujimori M; Izuo M; Kawai T; Takano A Gan No Rinsho; 1967 Oct; 13(10):855-60. PubMed ID: 5627465 [No Abstract] [Full Text] [Related]
2. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994 [TBL] [Abstract][Full Text] [Related]
3. Timing of surgery in relation to menstrual cycle does not predict the prognosis in primary breast cancer. Danish Breast Cancer Cooperative Group. Kroman N; Højgaard A; Andersen KW; Graversen HP; Afzelius P; Lokdam A; Juul C; Hoffmann J; Bentzon N; Mouridsen HT Eur J Surg Oncol; 1994 Aug; 20(4):430-5. PubMed ID: 8076704 [TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of immunocompetent cell infiltration of breast tumor tissue]. Perel'muter VM; Slonimskaia EM; Cherdyntseva NV; Afrimson EA Vopr Onkol; 1997; 43(6):596-8. PubMed ID: 9479358 [TBL] [Abstract][Full Text] [Related]
5. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Nielsen BS; Sehested M; Timshel S; Pyke C; Danø K Lab Invest; 1996 Jan; 74(1):168-77. PubMed ID: 8569179 [TBL] [Abstract][Full Text] [Related]
6. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients. Parr C; Gan CH; Watkins G; Jiang WG Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268 [TBL] [Abstract][Full Text] [Related]
7. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion. Hildenbrand R; Schaaf A Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473 [TBL] [Abstract][Full Text] [Related]
8. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597 [TBL] [Abstract][Full Text] [Related]
9. Cellular DNA contact and its correlation with histopathological prognostic parameters in carcinoma of the breast. Chaturvedi S; Singh S; Khanna HD; Khanna S; Khanna R Indian J Pathol Microbiol; 1998 Jul; 41(3):337-42. PubMed ID: 9805857 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of alpha-thymosins in breast cancer. Tsitsilonis OE; Bekris E; Voutsas IF; Baxevanis CN; Markopoulos C; Papadopoulou SA; Kontzoglou K; Stoeva S; Gogas J; Voelter W; Papamichail M Anticancer Res; 1998; 18(3A):1501-8. PubMed ID: 9673361 [TBL] [Abstract][Full Text] [Related]
11. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients. Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients. Scorilas A; Karameris A; Arnogiannaki N; Ardavanis A; Bassilopoulos P; Trangas T; Talieri M Br J Cancer; 2001 Jun; 84(11):1488-96. PubMed ID: 11384099 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of breast cancer biology. Oza AM; Tannock IF Hematol Oncol Clin North Am; 1994 Feb; 8(1):1-14. PubMed ID: 7512087 [TBL] [Abstract][Full Text] [Related]
14. [Expression of bcl-2 gene in relation to histologic type and grade, and prognosis of breast cancer]. Yang H; Sun Y; Liu F Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):490-2. PubMed ID: 11235572 [TBL] [Abstract][Full Text] [Related]
15. [Prognosis in cancer of the breast in relation to the topography of the tumor]. Rozenbakh VP Klin Lech Zlokach Novoobraz; 1968; 11():65-9. PubMed ID: 5725414 [No Abstract] [Full Text] [Related]
16. [The long-term prognosis of locally recurrent breast cancer after breast conserving treatment]. Hoofwijk AG; van der Ent FW; Heeren PA; Hulsewé KW; Stroeken HJ Ned Tijdschr Geneeskd; 2006 Mar; 150(9):521-2; author reply 522-3. PubMed ID: 16553056 [No Abstract] [Full Text] [Related]
17. [Prognostic significance of desmoplasia in breast carcinoma. A preliminary clinical study]. Mezi S; Aloise G; Marzullo A; Marchei P; Di Benedetto A; Modica A; Vasaturo F; Modesti M G Chir; 1997 May; 18(5):263-8. PubMed ID: 9312252 [TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse. Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194 [TBL] [Abstract][Full Text] [Related]
19. Clinical studies of breast cancer in the inner half. Kataoka T; Nishiki M; Yamane M; Kishi N; Amano K; Okumichi T; Ezaki H Hiroshima J Med Sci; 1984 Dec; 33(4):709-14. PubMed ID: 6534929 [No Abstract] [Full Text] [Related]
20. Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report. Hartveit F Oncol Rep; 1998; 5(2):423-6. PubMed ID: 9468572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]